Last Updated

22 May 2023

Optimisation of the delivery and cost-effectiveness of combination drug treatment for malaria in Africa and Asia

Objectives

To support a coordinated research programme to identify how best to optimise the delivery and cost-effectiveness of combination drug treatment for malaria in Africa and Asia across a range of epidemiological and healthcare settings.

Principal Institution(s)

External Reference
Gates Foundation grant information

Related Resources
Guidance & Strategy
|

The use of rectal artesunate as a pre-referral treatment for severe Plasmodium falciparum malaria, 2023 update

World Health Organization (WHO)

Report
|

Technical consultation to review the effectiveness of rectal artesunate used as pre-referral treatment of severe malaria in children

World Health Organization (WHO)

Related Projects

- | $672k

Aging: Long-term hidden cost of infections
Swedish Research Council (SRC), Sweden, Lund University (LU), Sweden | Muhammad Asghar | Kenya, Tanzania, Netherlands, Sweden
- | $475k

End malaria on islands in Vanuatu: the rollout of innovative anti-Plasmodium vivax strategies
Swedish Research Council (SRC), Sweden, Karolinska Institute (KI), Sweden | Akira Kaneko, George Taleo | Sweden, Vanuatu
Thematic Categories
Leadership & Governance
Combination Interventions
Drug-based Strategies

Date

2007 Jan - 2016 Dec

Total Project Funding

$39,775,400
Project Site
United Kingdom